Patterns of triptans use: A study based on the records of a community pharmaceutical department

Cephalalgia

Volumn 27, Issue 9, 2007, Pages 1000-1004

  Pavone, E ^a   Banfi, R ^a   Vaiani, M ^a   Panconesi, A ^a  

^a ASL 11   (Italy)

Author keywords

Prescription data; Triptan abusers; Triptans; Usage patterns

Indexed keywords

ALMOTRIPTAN; ELETRIPTAN; FROVATRIPTAN; RIZATRIPTAN; SUMATRIPTAN; TRIPTAN DERIVATIVE; ZOLMITRIPTAN;

ADOLESCENT; ADULT; AGED; ARTICLE; DRUG ABUSE; DRUG INDUSTRY; DRUG UTILIZATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MIGRAINE; PRESCRIPTION;

CHEMISTRY, PHARMACEUTICAL; COMMUNITY HEALTH CENTERS; DRUG UTILIZATION; DRUG UTILIZATION REVIEW; HUMANS; ITALY; MIGRAINE DISORDERS; PHARMACY; PRESCRIPTIONS, DRUG; REGISTRIES; TRYPTAMINES;

EID: 34548061015     PISSN: 03331024     EISSN: 14682982     Source Type: Journal    
DOI: 10.1111/j.1468-2982.2007.01401.x     Document Type: Article

References (19)

1. Lipton RB, Diamond S, Reed M, Diamond ML, Stewart WF. Migraine diagnosis and treatment: results from the American Migraine Study II. Headache 2001 41: 638 45.
2. MacGregor EA, Brandes J, Eikermann A. Migraine prevalence and treatment patterns: the global migraine and zolmitriptan evaluation survey. Headache 2003 43: 19 26.
3. De Diego EV, Lanteri-Minet MC. Recognition and management of migraine in primary care: influence of functional impact measured by the headache impact test (HIT). Cephalalgia 2005 25: 184 19.
4. Headache Classification Committee of the International Headache Society. The International Classification of Headache Disorders. Cephalagia 2004 24 (Suppl. 1 1 160.
5. Nachit-Ouinekh F, Dartigues J-F, Chrysostome V, Henry P, Sourgen C, El Hasnaoui A. Evolution of migraine after 10-year follow-up. Headache 2005 45: 1280 7.
6. Woeber C, Woeber-Bingoel C, Schmidt K, Zingerle R, Hattinger N, Hartl T et al. Symptomatology, impact and treatment of 6000 headache attacks and episodes: the pamina study. Cephalalgia 2005 25: 646.
7. Ferrari MD, Roon KI, Lipton RB, Goadsby PJ. Oral triptans (serotonin 5-HT 1b/1d agonists) in acute migraine treatment: a meta-analysis of 53 trials. Lancet 2001 358: 1668 75.
8. Lohman JJHM, van der Kuy-de Ree MM. Patterns of specific antimigraine drug use - a study based on the records of 18 community pharmacies. Cephalalgia 2005 25: 214 8.
9. Roncolato M, Fabbri L, Recchia G, Cavazzutti L, Visona G, Brignoli O, Medea G. An epidemiological study to assess migraine prevalence in a sample of Italian population presenting to their GPs. Eur Neurol 2000 43: 102 6.
10. Gaist D, Andersen M, Aarup AL, Hallas J, Gram LF. Use of sumatriptan in Denmark in 1994-5: an epidemiological analysis of nationwide prescription data. Br J Clin Pharmacol 1997 43: 429 33.
11. Rahimtoola H, Buurma H, Tijssen CC, Leufkens HG, Egberts ACG. Single use of sumatriptan: a patient interview study. Headache 2003 43: 109 16.
12. Lygberg AC, Rasmussen BK, Jorgensen T, Jensen R. Prognosis of migraine and tension-type headache: a population-based follow-up study. Neurology 2005 65: 580 5.
13. Lipton RB, Bigal ME, Goadsby PJ. Double-blind clinical trials of oral triptans vs other classes of acute migraine medication - a review. Cephalalgia 2004 24: 321 32.
14. Goldstein J, Silberstein SD, Saper JR, Elkind AH, Smith TR, Gallagher RM et al. Acetaminophen, aspirin, and caffeine versus sumatriptan succinate in the early treatment of migraine. Headache 2005 45: 973 82.
15. Rahimtoola H, Egberts ACG, Buurma H, Tijssen CC, Leufkens HG. Patterns of ergotamine and sumatriptan use in the Netherlands from 1992 to 1997. Cephalalgia 2001 21: 596 603.
16. Limmroth V, Katsarava Z, Fritsche G, Przywara S, Diener HC. Features of medication overuse headache following overuse of different acute headache drugs. Neurology 2002 59: 1011 4.
17. Wenzel RG, Lipton RB, Diamond ML, Cady R. Migraine therapy: a survey of pharmacists' knowledge, attitudes, and practice patterns. Headache 2005 45: 47 52.
18. Bianco A, Parente MM, De Caro E, Iannacchero R, Cannistrà U, Angelillo IF. Evidence-based medicine and headache patient management by general practitioners in Italy. Cephalalgia 2005 25: 767 75.
19. Sondergaard J, Foged A, Kragstrup J, Gaist D, Gram LF, Sindrup SH et al. Intensive community pharmacy intervention had little impact on triptan consumption: a randomized controlled trial. Scand J Prim Health Care 2006 24: 16 21.